Blue Chip Partners’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3M Buy
20,475
+2,172
+12% +$316K 0.19% 59
2026
Q1
$2.64M Sell
18,303
-707
-4% -$107K 0.19% 53
2025
Q4
$2.72M Sell
19,010
-1,017
-5% -$150K 0.2% 52
2025
Q3
$3.08M Sell
20,027
-258
-1% -$40.3K 0.23% 49
2025
Q2
$3.23M Buy
20,285
+74
+0.4% +$12.1K 0.26% 50
2025
Q1
$3.44M Sell
20,211
-470
-2% -$78.7K 0.3% 49
2024
Q4
$3.47M Buy
20,681
+105
+0.5% +$17.9K 0.3% 46
2024
Q3
$3.56M Sell
20,576
-264
-1% -$44.8K 0.31% 48
2024
Q2
$3.44M Sell
20,840
-139
-0.7% -$22.7K 0.32% 45
2024
Q1
$3.4M Sell
20,979
-549
-3% -$86.1K 0.33% 44
2023
Q4
$3.15M Buy
21,528
+33
+0.2% +$4.89K 0.33% 45
2023
Q3
$3.14M Sell
21,495
-185
-0.9% -$28.3K 0.37% 40
2023
Q2
$3.29M Buy
21,680
+24
+0.1% +$3.62K 0.37% 45
2023
Q1
$3.22M Buy
21,656
+153
+0.7% +$21.9K 0.38% 47
2022
Q4
$3.26M Buy
21,503
+409
+2% +$57.3K 0.41% 47
2022
Q3
$2.66M Buy
21,094
+397
+2% +$56.4K 0.37% 48
2022
Q2
$2.98M Buy
20,697
+155
+0.8% +$23.3K 0.38% 49
2022
Q1
$3.14M Buy
20,542
+104
+0.5% +$16.3K 0.39% 49
2021
Q4
$3.34M Buy
20,438
+653
+3% +$97K 0.42% 43
2021
Q3
$2.77M Buy
19,785
+733
+4% +$104K 0.39% 41
2021
Q2
$2.57M Sell
19,052
-1,701
-8% -$230K 0.37% 43
2021
Q1
$2.81M Sell
20,753
-65,302
-76% -$8.52M 0.43% 40
2020
Q4
$12M Buy
86,055
+27,072
+46% +$3.78M 1.87% 29
2020
Q3
$8.2M Buy
58,983
+12,192
+26% +$1.62M 1.46% 29
2020
Q2
$5.59M Buy
46,791
+11,400
+32% +$1.33M 1.1% 33
2020
Q1
$3.89M Buy
35,391
+1,406
+4% +$169K 0.97% 31
2019
Q4
$4.25M Sell
33,985
-1,144
-3% -$140K 0.81% 37
2019
Q3
$4.37M Buy
35,129
+1,424
+4% +$168K 0.92% 34
2019
Q2
$3.7M Sell
33,705
-208
-0.6% -$22.2K 0.83% 36
2019
Q1
$3.53M Buy
33,913
+386
+1% +$37.6K 0.84% 38
2018
Q4
$3.08M Sell
33,527
-2,236
-6% -$200K 0.78% 38
2018
Q3
$2.98M Sell
35,763
-10,177
-22% -$832K 0.73% 40
2018
Q2
$3.59M Sell
45,940
-28,558
-38% -$2.15M 0.95% 38
2018
Q1
$5.91M Buy
74,498
+668
+0.9% +$55.7K 1.63% 21
2017
Q4
$6.78M Buy
73,830
+42
+0.1% +$3.78K 2.01% 14
2017
Q3
$6.71M Buy
73,788
+1,670
+2% +$152K 2.16% 11
2017
Q2
$6.29M Buy
72,118
+566
+0.8% +$49.9K 2.19% 9
2017
Q1
$6.43M Buy
71,552
+363
+0.5% +$32.2K 2.43% 6
2016
Q4
$5.99M Buy
71,189
+7,966
+13% +$679K 2.35% 8
2016
Q3
$5.67M Buy
63,223
+1,006
+2% +$87.4K 2.51% 6
2016
Q2
$5.27M Buy
62,217
+2,851
+5% +$234K 2.37% 9
2016
Q1
$4.89M Buy
59,366
+4,577
+8% +$369K 2.38% 10
2015
Q4
$4.35M Buy
54,789
+3,720
+7% +$284K 2.27% 10
2015
Q3
$3.67M Buy
51,069
+2,798
+6% +$210K 2.34% 10
2015
Q2
$3.78M Buy
48,271
+4,889
+11% +$393K 2.42% 11
2015
Q1
$3.56M Sell
43,382
-207
-0.5% -$17.8K 2.41% 12
2014
Q4
$3.97M Buy
+43,589
New +$3.84M 2.77% 9

Other funds holding PG

Blue Chip Partners's PG Position: Q2 2026 in Review

Blue Chip Partners increased its Procter & Gamble (PG) stake by 12% in Q2 2026, buying an estimated $316K and bringing the position to 20,475 shares worth $3M. The position accounts for 0.19% of the portfolio, ranked #59.

Blue Chip Partners first reported a position in PG in Q4 2014 and has held it in 47 quarters since. The position peaked at $12M in Q4 2020. 4,000 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Blue Chip Partners held 20,475 shares of Procter & Gamble worth $3M as of Q2 2026.
  • Blue Chip Partners bought 2,172 Procter & Gamble shares in Q2 2026, an estimated $316K.
  • Procter & Gamble made up 0.19% of Blue Chip Partners's portfolio in Q2 2026, its #59 holding.
  • Blue Chip Partners first reported a position in Procter & Gamble in Q4 2014 and has held it in 47 quarters since.
  • Blue Chip Partners's Procter & Gamble position peaked at $12M in Q4 2020.
  • 4,000 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Blue Chip Partners's 13F filing for Q2 2026, filed 14 Aug 2026.